Submission Details
| 510(k) Number | K151917 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | July 13, 2015 |
| Decision Date | October 06, 2015 |
| Days to Decision | 85 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Statement |
K151917 is an FDA 510(k) clearance for the ARIES System, a Real Time Nucleic Acid Amplification System (Class II — Special Controls, product code OOI), submitted by Luminex Corporation (Austin, US). The FDA issued a Cleared decision on October 6, 2015, 85 days after receiving the submission on July 13, 2015. This device falls under the Chemistry review panel. Regulated under 21 CFR 862.2570.
| 510(k) Number | K151917 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | July 13, 2015 |
| Decision Date | October 06, 2015 |
| Days to Decision | 85 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Statement |
| Product Code | OOI — Real Time Nucleic Acid Amplification System |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.2570 |
| Definition | The System Is A Clinical Multiplex Instrument Intended To Measure And Sort Multiple Signals Generated My Multiple Probes, Intercalating Dyes, Or Other Ligands In An Assay From A Clinical Sample. Signals May Be Generated By Fluorescence Or Other Phenomena And May Be Measured Using Filters On A Photodiode Or Other Detector. It May Integrate Sample And/or Reagent Handling, Amplification, Dedicated Instrument Control, Data Acquisition Software, Raw Data Storage Mechanisms And Other Essential Hardware Components Along With The Signal Reader Unit. The System Is Used With Specific Assays To Comprise An Assay Test System. |